Global Immunology Drug Market Research Report 2021

1 Immunology Drug Market Overview

• 1.1 Product Overview and Scope of Immunology Drug
• 1.2 Immunology Drug Segment by Type
  • 1.2.1 Global Immunology Drug Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Monoclonal Antibodies (mAb)
  • 1.2.3 Antibody Drug Conjugates
  • 1.2.4 Interferon and Cytokine therapies
  • 1.2.5 Immunosuppressive medication
• 1.3 Immunology Drug Segment by Application
  • 1.3.1 Immunology Drug Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Cancer Research Centers and Institutes
• 1.4 Global Immunology Drug Market Size Estimates and Forecasts
  • 1.4.1 Global Immunology Drug Revenue 2016-2027
  • 1.4.2 Global Immunology Drug Sales 2016-2027
  • 1.4.3 Immunology Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Immunology Drug Market Competition by Manufacturers

• 2.1 Global Immunology Drug Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Immunology Drug Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Immunology Drug Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Immunology Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Immunology Drug Market Competitive Situation and Trends
  • 2.5.1 Immunology Drug Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Immunology Drug Players Market Share by Revenue
  • 2.5.3 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Immunology Drug Retrospective Market Scenario by Region

• 3.1 Global Immunology Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Immunology Drug Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Immunology Drug Market Facts & Figures by Country
  • 3.3.1 North America Immunology Drug Sales by Country
  • 3.3.2 North America Immunology Drug Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Immunology Drug Market Facts & Figures by Country
  • 3.4.1 Europe Immunology Drug Sales by Country
  • 3.4.2 Europe Immunology Drug Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Immunology Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Immunology Drug Sales by Region
  • 3.5.2 Asia Pacific Immunology Drug Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Immunology Drug Market Facts & Figures by Country
  • 3.6.1 Latin America Immunology Drug Sales by Country
  • 3.6.2 Latin America Immunology Drug Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Immunology Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Immunology Drug Sales by Country
  • 3.7.2 Middle East and Africa Immunology Drug Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Immunology Drug Historic Market Analysis by Type

• 4.1 Global Immunology Drug Sales Market Share by Type (2016-2021)
• 4.2 Global Immunology Drug Revenue Market Share by Type (2016-2021)
• 4.3 Global Immunology Drug Price by Type (2016-2021)

5 Global Immunology Drug Historic Market Analysis by Application

• 5.1 Global Immunology Drug Sales Market Share by Application (2016-2021)
• 5.2 Global Immunology Drug Revenue Market Share by Application (2016-2021)
• 5.3 Global Immunology Drug Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Abbott Laboratories
  • 6.1.1 Abbott Laboratories Corporation Information
  • 6.1.2 Abbott Laboratories Description and Business Overview
  • 6.1.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Abbott Laboratories Product Portfolio
  • 6.1.5 Abbott Laboratories Recent Developments/Updates
• 6.2 Active Biotech
  • 6.2.1 Active Biotech Corporation Information
  • 6.2.2 Active Biotech Description and Business Overview
  • 6.2.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Active Biotech Product Portfolio
  • 6.2.5 Active Biotech Recent Developments/Updates
• 6.3 Eli Lilly and Company
  • 6.3.1 Eli Lilly and Company Corporation Information
  • 6.3.2 Eli Lilly and Company Description and Business Overview
  • 6.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Eli Lilly and Company Product Portfolio
  • 6.3.5 Eli Lilly and Company Recent Developments/Updates
• 6.4 Autoimmune Inc.
  • 6.4.1 Autoimmune Inc. Corporation Information
  • 6.4.2 Autoimmune Inc. Description and Business Overview
  • 6.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Autoimmune Inc. Product Portfolio
  • 6.4.5 Autoimmune Inc. Recent Developments/Updates
• 6.5 Pfizer
  • 6.5.1 Pfizer Corporation Information
  • 6.5.2 Pfizer Description and Business Overview
  • 6.5.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Pfizer Product Portfolio
  • 6.5.5 Pfizer Recent Developments/Updates
• 6.6 GlaxoSmithKline plc
  • 6.6.1 GlaxoSmithKline plc Corporation Information
  • 6.6.2 GlaxoSmithKline plc Description and Business Overview
  • 6.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 GlaxoSmithKline plc Product Portfolio
  • 6.6.5 GlaxoSmithKline plc Recent Developments/Updates
• 6.7 Seattle Genetics
  • 6.6.1 Seattle Genetics Corporation Information
  • 6.6.2 Seattle Genetics Description and Business Overview
  • 6.6.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Seattle Genetics Product Portfolio
  • 6.7.5 Seattle Genetics Recent Developments/Updates
• 6.8 Genentech
  • 6.8.1 Genentech Corporation Information
  • 6.8.2 Genentech Description and Business Overview
  • 6.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Genentech Product Portfolio
  • 6.8.5 Genentech Recent Developments/Updates
• 6.9 F. Hoffmann-La Roche Ltd.
  • 6.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
  • 6.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
  • 6.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 F. Hoffmann-La Roche Ltd. Product Portfolio
  • 6.9.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
• 6.10 Eisai Co.
  • 6.10.1 Eisai Co. Corporation Information
  • 6.10.2 Eisai Co. Description and Business Overview
  • 6.10.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Eisai Co. Product Portfolio
  • 6.10.5 Eisai Co. Recent Developments/Updates
• 6.11 Bayer AG
  • 6.11.1 Bayer AG Corporation Information
  • 6.11.2 Bayer AG Immunology Drug Description and Business Overview
  • 6.11.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Bayer AG Product Portfolio
  • 6.11.5 Bayer AG Recent Developments/Updates
• 6.12 Sanofi Aventis LLC.
  • 6.12.1 Sanofi Aventis LLC. Corporation Information
  • 6.12.2 Sanofi Aventis LLC. Immunology Drug Description and Business Overview
  • 6.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Sanofi Aventis LLC. Product Portfolio
  • 6.12.5 Sanofi Aventis LLC. Recent Developments/Updates

7 Immunology Drug Manufacturing Cost Analysis

• 7.1 Immunology Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Immunology Drug
• 7.4 Immunology Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Immunology Drug Distributors List
• 8.3 Immunology Drug Customers

9 Immunology Drug Market Dynamics

• 9.1 Immunology Drug Industry Trends
• 9.2 Immunology Drug Growth Drivers
• 9.3 Immunology Drug Market Challenges
• 9.4 Immunology Drug Market Restraints

10 Global Market Forecast

• 10.1 Immunology Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Immunology Drug by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Immunology Drug by Type (2022-2027)
• 10.2 Immunology Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Immunology Drug by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Immunology Drug by Application (2022-2027)
• 10.3 Immunology Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Immunology Drug by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Immunology Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List